Gut Microbiota and Clinical Disease: Obesity and Nonalcoholic Fatty Liver Disease.
10.5223/pghn.2013.16.1.22
- Author:
Ji Sook PARK
1
;
Ji Hyun SEO
;
Hee Shang YOUN
Author Information
1. Department of Pediatrics, Gyeongsang National University School of Medicine, Jinju, Korea. csassi@hanmail.net
- Publication Type:Review
- Keywords:
Obesity;
Microbiota;
Non-alcoholic fatty liver disease
- MeSH:
Cardiovascular Diseases;
Fatty Liver;
Hyperlipidemias;
Hypertension;
Metagenome;
Obesity;
Prevalence
- From:Pediatric Gastroenterology, Hepatology & Nutrition
2013;16(1):22-27
- CountryRepublic of Korea
- Language:English
-
Abstract:
The prevalence of obesity is increasing worldwide. Obesity can cause hyperlipidemia, hypertension, cardiovascular diseases, metabolic syndrome and non-alcoholic fatty liver disease (NAFLD). Many environmental or genetic factors have been suggested to contribute to the development of obesity, but there is no satisfactory explanation for its increased prevalence. This review discusses the latest updates on the role of the gut microbiota in obesity and NAFLD.
